Jude Concepcion | Eisai Inc.

The National Law Journal


Jude Concepcion, the senior legal director at Eisai Inc., took a pugnacious stance when battling pharmaceutical fraud charges; he helped his company settle an off-label marketing case for $11 million without a requirement to overhaul company compliance. The case about improper marketing of the company's anti-epileptic drug Zonegran settled in December 2010 with the drug's original owner, Elan Corp., footing the bulk of the $214.5 million bill.

This content has been archived. It is available exclusively through our partner LexisNexis®.

To view this content, please continue to Lexis Advance®.

Continue to Lexis Advance®

Not a Lexis Advance® Subscriber? Subscribe Now

Why am I seeing this?

LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® customers will be able to access and use ALM's content by subscribing to the LexisNexis® services via Lexis Advance®. This includes content from the National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.

ALM's content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.

For questions call 1-877-256-2472 or contact us at customercare@alm.com

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article #1202520555829

Thank you!

This article's comments will be reviewed.